Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,462 | 3,954 | 3,917 | 3,433 | 3,590 | 3,821 | 4,417 | 3,942 | 4,296 | 4,173 | 4,517 | 4,336 | |
| COGS | 1,127 | 1,232 | 1,330 | 1,183 | 1,183 | 1,359 | 1,473 | 1,405 | 1,547 | 1,339 | 1,399 | 1,468 |
| Gross profit | 2,335 | 2,722 | 2,588 | 2,250 | 2,408 | 2,462 | 2,944 | 2,537 | 2,749 | 2,834 | 3,117 | 2,868 |
| 1,618 | 1,819 | 1,674 | 1,630 | 1,722 | 1,710 | 1,866 | 1,788 | 1,913 | 2,000 | 2,097 | 2,021 | |
| 717 | 903 | 913 | 620 | 685 | 752 | 1,078 | 749 | 835 | 834 | 1,020 | 847 | |
| OPM % | 20.7% | 22.8% | 23.3% | 18.1% | 19.1% | 19.7% | 24.4% | 19% | 19.5% | 20% | 22.6% | 19.5% |
| Depreciation | 389 | 415 | 407 | 405 | 420 | 425 | 436 | 455 | 473 | 515 | 513 | 547 |
| Interest | 248 | 267 | 227 | 236 | 226 | 223 | 212 | 277 | 272 | 210 | 232 | 213 |
| 134 | 587 | 40 | 1,167 | 59 | 53 | 57 | 80 | 81 | -176 | -28 | 41 | |
| Profit before tax | 214 | 808 | 319 | 1,146 | 98 | 156 | 487 | 97 | 171 | -68 | 248 | 128 |
| Tax | 42 | 55 | 96 | 284 | 71 | 75 | 27 | 8 | 39 | -16 | 49 | -9 |
| Tax % | 19.4% | 6.8% | 30.1% | 24.8% | 72.5% | 48% | 5.6% | 8% | 22.5% | -23.6% | 19.8% | -7.2% |
| 173 | 753 | 223 | 862 | 27 | 81 | 459 | 89 | 133 | -52 | 199 | 137 | |
| PAT margin % | 5% | 19.1% | 5.7% | 25.1% | 0.8% | 2.1% | 10.4% | 2.3% | 3.1% | -1.2% | 4.4% | 3.2% |
| EPS (₹) | 1.1 | 5.5 | 1.1 | 5.5 | -0.1 | 0.2 | 2.9 | 0.3 | 0.7 | 1.1 | 0.8 | 0.9 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | — |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +49.3% | +34.4% | +3.8% | +0.3% | +3.7% | -3.3% | +12.8% | +14.8% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Biosimilars | 2,855.6 | 171.4 | 48,653.3 | 21,489.4 | 27,163.9 |
| Generics | 759.7 | -30.9 | 9,386.5 | 3,865.8 | 5,520.7 |
| +19.6% |
| +9.2% |
| +2.3% |
| +10% |
| PAT YoY % | +111.1% | — | -46.2% | +478.8% | -84.3% | -89.2% | +106.1% | -89.6% | +390% | -163.9% | -56.8% | +53.4% |
| Services | 736 | -5.7 | 6,745.2 | 1,879.1 | 4,866.1 |
₹ crore by quarter